AU532290B2 - Canine parvovirus vaccine - Google Patents

Canine parvovirus vaccine

Info

Publication number
AU532290B2
AU532290B2 AU54056/79A AU5405679A AU532290B2 AU 532290 B2 AU532290 B2 AU 532290B2 AU 54056/79 A AU54056/79 A AU 54056/79A AU 5405679 A AU5405679 A AU 5405679A AU 532290 B2 AU532290 B2 AU 532290B2
Authority
AU
Australia
Prior art keywords
canine parvovirus
parvovirus vaccine
vaccine
canine
parvovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU54056/79A
Other languages
English (en)
Other versions
AU5405679A (en
Inventor
Max J.G. Appel
Leland E. Carmichael
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Original Assignee
Cornell Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc filed Critical Cornell Research Foundation Inc
Publication of AU5405679A publication Critical patent/AU5405679A/en
Application granted granted Critical
Publication of AU532290B2 publication Critical patent/AU532290B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU54056/79A 1978-12-20 1979-12-20 Canine parvovirus vaccine Ceased AU532290B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US971296 1978-12-20
US05/971,296 US4193991A (en) 1978-12-20 1978-12-20 Canine parvovirus vaccine

Publications (2)

Publication Number Publication Date
AU5405679A AU5405679A (en) 1980-06-26
AU532290B2 true AU532290B2 (en) 1983-09-22

Family

ID=25518175

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54056/79A Ceased AU532290B2 (en) 1978-12-20 1979-12-20 Canine parvovirus vaccine

Country Status (11)

Country Link
US (1) US4193991A (enExample)
EP (1) EP0020743A1 (enExample)
JP (1) JPS6330287B2 (enExample)
AU (1) AU532290B2 (enExample)
CA (1) CA1138772A (enExample)
DE (1) DE2953417C2 (enExample)
GB (1) GB2048071B (enExample)
NL (1) NL7920193A (enExample)
NZ (1) NZ192477A (enExample)
SE (1) SE423312B (enExample)
WO (1) WO1980001243A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303645A (en) * 1980-04-18 1981-12-01 Cornell Research Foundation, Inc. Modified living canine parvovirus vaccine
JPS58408B2 (ja) * 1980-09-04 1983-01-06 株式会社 微生物化学研究所 イヌパルボウイルス感染症不活化ワクチン
US4572834A (en) * 1984-04-10 1986-02-25 Clinical Reference Laboratory, Inc. Biologic and method of preparing same
GB8502399D0 (en) * 1985-01-31 1985-03-06 Akzo Nv Canine parvovirus vaccines
US4971793A (en) * 1988-05-09 1990-11-20 Boyce Thompson Institute For Plant Research, Inc. Subunit canine parvovirus vaccine
DE69023140T2 (de) * 1989-08-08 1996-03-21 Webster Arthur Pty Ltd Attenuiertes hundeparvovirus (cpv), cpv enthaltender impfstoff und verfahren zur verhütung von infektionen durch cpv bei hunden.
AU633349B2 (en) * 1989-08-08 1993-01-28 Fort Dodge Australia Pty Limited Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs
US5814510A (en) * 1994-11-08 1998-09-29 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
US5885585A (en) * 1994-11-08 1999-03-23 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
US6168915B1 (en) * 1998-04-24 2001-01-02 Diagnostic Hybrids, Inc. Mixed cell diagnostic systems
US20060094105A1 (en) 1998-04-24 2006-05-04 University Hospitals Of Cleveland Mixed cell diagnostic systems for detection of respiratory, herpes and enteric viruses
US6946291B2 (en) * 1998-04-24 2005-09-20 University Hospitals Of Cleveland Mixed cell diagnostic systems
CA2510189A1 (en) * 2002-12-19 2004-07-08 Thomas Gore Trivalent vaccine with maternal antibody transfer via the milk
RU2242994C1 (ru) * 2003-08-05 2004-12-27 Федеральное государственное учреждение Всероссийский научно-исследовательский институт защиты животных Штамм № r-72 вниизж парвовируса собак для изготовления диагностических и вакцинных препаратов
PL2236155T3 (pl) 2004-09-09 2012-10-31 Novartis Ag Zmniejszenie potencjalnego zagrożenia jatrogennego związanego ze szczepionkami przeciwko grypie
US7435588B2 (en) * 2005-09-20 2008-10-14 Diagnostic Hybrids, Inc. Systems for detection and production of respiratory, herpes and enteric viruses
US8227583B2 (en) * 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
CN106048082A (zh) * 2007-06-14 2016-10-26 俄克拉荷马州大学评议会 包含犬细小病毒遗传性变体的疫苗
EP2391713A1 (en) 2009-01-30 2011-12-07 The Board Of Regents For Oklahoma State University Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs
EP2488634A4 (en) 2009-10-14 2013-04-03 Univ Oklahoma State ISOLATION OF A VIRUS RELATED TO DOG PARVOVIRUS 2 IN A WASHBASIN
CN104324272A (zh) * 2014-11-23 2015-02-04 烟台海研制药有限公司 治疗犬细小病毒病的中药组合物
AU2021223783A1 (en) 2020-02-21 2022-08-18 Intervet International B.V. Novel erythroparvovirus associated with respiratory distress in equine

Also Published As

Publication number Publication date
GB2048071A (en) 1980-12-10
JPS6330287B2 (enExample) 1988-06-17
CA1138772A (en) 1983-01-04
DE2953417C2 (de) 1987-08-20
GB2048071B (en) 1983-09-21
NZ192477A (en) 1983-02-15
EP0020743A1 (en) 1981-01-07
SE423312B (sv) 1982-05-03
SE8005824L (sv) 1980-08-19
DE2953417T1 (enExample) 1981-01-29
WO1980001243A1 (en) 1980-06-26
US4193991A (en) 1980-03-18
AU5405679A (en) 1980-06-26
NL7920193A (nl) 1980-10-31
JPS55501177A (enExample) 1980-12-25

Similar Documents

Publication Publication Date Title
AU532290B2 (en) Canine parvovirus vaccine
AU535420B2 (en) Disposable portion package
AU560817B2 (en) Improved sleeve
AU535346B2 (en) Insecticidal perhaloalkylvinylcyclo-propanecarboxylates
ZA794416B (en) Pasteurellois vaccines
AU5286979A (en) Wheel-chair
AU5272679A (en) Marker
AU524314B2 (en) Heterotypic canine parvovirus vaccine
AU524452B2 (en) Surgical endoprotheses
AU513657B2 (en) Dental surveyor
DE3163729D1 (en) Modified living canine parvovirus vaccine
JPS5589231A (en) Vaccine
AU527269B2 (en) Insecticide
AU525504B2 (en) Intra-respiratory vaccine
AU4577979A (en) Sone-aural dentistry
AU4177778A (en) Anticalculus dental composition
AU7155381A (en) Modified living canine parvovirus vaccine
SU694500A1 (ru) Хлоргидрат 1-фенилселено-4-фенил-4-гексаметилениминобутина-2, обладающий биоантиоксидантным действием
AU522971B2 (en) Insecticide
JPS54140715A (en) Vaccine stabilizer
AU527659B2 (en) Anti-clostridiosis vaccine
AU501068B2 (en) Douche attachment
AU534625B2 (en) Clostridal vaccine
AU3265878A (en) Douche attachment
ZA794399B (en) Vaccine